Ironwood Pharmaceuticals | IRWD - Deudores Comerciales

Precio De Mercado
3.50
Cambio Diario
-0.12 -3.31%
Mensual
-27.69%
Anual
133.33%
Q1 Expectativa
3.32




Deudores Comerciales Cambio Fecha
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
Akebia Therapeutics USD 61.54M 27.17M 2025-03
Almirall EUR 175.93M 17.87M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amarin USD 127.31M 8.18M 2025-09
Ardelyx USD 76.61M 14.06M 2025-09
Astellas Pharma JPY 810.23B 75.43B 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Charles River Laboratories USD 1.43B 54.59M 2025-12
Coherus Biosciences USD 62.44M 59.9M 2025-03
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Esperion Therapeutics USD 60.36M 5.75M 2024-06
Exact Sciences USD 306.05M 47.28M 2025-09
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Incyte USD 1.02B 128.52M 2025-12
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Karyopharm Therapeutics USD 31.78M 6.82M 2024-09
Lexicon Pharmaceuticals USD 2.62M 1.09M 2024-06
MacroGenics USD 69.23M 56.7M 2025-09
Moderna USD 184M 862M 2025-12
Myriad Genetics USD 118M 19M 2025-09
Pacira USD 124.07M 8.8M 2025-12
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Takeda JPY 757.92B 55.68B 2025-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12